Company intelligence / Profile preview

Greenspace Health

Toronto, Ontario, Canadagreenspacehealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Greenspace Health’s Measurement-Based Care platform has been implemented in over 500 organizations and used by more than 2.5 million clients. Organizations using the platform have seen an average symptom improvement of 49% and an average therapeutic alliance score of 81%, demonstrating measurable impact on care quality. The company continues to innovate with its MBC 2.0 release leveraging AI and predictive analytics to further improve outcomes.

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapy (Measurement-Based Care platform; not a drug or biologic company)
Industry: Digital Health Medical Devices

Partnerships

Project HEAL (educational partnership for eating disorder treatment data-driven approaches)

Beyond the preview

Go deeper on Greenspace Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Greenspace Health.

Explore the full profile